TRAVERSA Trademark

Trademark Overview

On Monday, November 27, 2023, a trademark application was filed for TRAVERSA with the United States Patent and Trademark Office. The USPTO has given the TRAVERSA trademark a serial number of 98286650. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, October 28, 2024. This trademark is owned by VeinWay Ltd.. The TRAVERSA trademark is filed in the Medical Instrument Products category with the following description:

catheters; medical device, namely, catheters for the treatment of chronic venous disease; medical device, namely, catheters for recanalization of chronic venous occlusions; medical device for venous recanalization
traversa

General Information

Serial Number98286650
Word MarkTRAVERSA
Filing DateMonday, November 27, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicescatheters; medical device, namely, catheters for the treatment of chronic venous disease; medical device, namely, catheters for recanalization of chronic venous occlusions; medical device for venous recanalization
Translation of Words in MarkThe English translation of "Traversa" in the mark is "crossbeam".

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVeinWay Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOr-Yehuda 6037606
IL

Trademark Events

Event DateEvent Description
Thursday, November 30, 2023NEW APPLICATION ENTERED
Wednesday, June 26, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 17, 2024NON-FINAL ACTION WRITTEN
Monday, August 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2024ASSIGNED TO EXAMINER
Saturday, October 19, 2024ASSIGNED TO EXAMINER
Monday, October 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 28, 2024NON-FINAL ACTION WRITTEN
Monday, October 28, 2024NON-FINAL ACTION E-MAILED
Monday, August 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

traversa catheters venous device medical chronic namely recanalization occlusions treatment disease